Drishti Agarwal TOPLINE:Once-weekly insulin icodec shows a higher glycated A1c reduction than once-daily basal insulin analogs in patients with type 2 diabetes (T2D), without major safety concerns. METHODOLOGY:A meta-analysis of five phase 3 ONWARDS randomized controlled trials included 3764 patients with T2D.The trials compared the effects of the weekly insulin icodec with those of the...
Tag: <span>Weekly insulin</span>
Post
Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin
THE ENDOCRINE SOCIETY WASHINGTON–A new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin, according to a phase 2 clinical trial. The study results, which will be presented at ENDO 2021, the Endocrine Society’s annual meeting, compared an investigational drug...